Publications

Export 2549 results:
Sort by: Author [ Title  (Desc)] Type Year
A B C D E F G [H] I J K L M N O P Q R S T U V W X Y Z   [Show ALL]
H
El-Saiedi, S. A., Z. S. Seliem, and R. I. Esmail, "Hypertrophic cardiomyopathy: prognostic factors and survival analysis in 128 Egyptian patients", Cardiology in the Young, vol. 24, issue 4, pp. 702-708, 2014.
El-Kady, N. M., G. Esmat, E. H. Mahmoud, S. K. Darweesh, S. H. Mahmoud, and W. A. Elagawy, "Hypertonic saline-enhanced radiofrequency versus chemoembolization sequential radiofrequency in the treatment of large hepatocellular carcinoma", EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, vol. 25, no. 5, pp. 628-633, MAY, 2013. Abstract
n/a
El-Kady, N. M., G. Esmat, E. H. Mahmoud, S. K. Darweesh, S. H. Mahmoud, and W. A. Elagawy, "Hypertonic saline-enhanced radiofrequency versus chemoembolization sequential radiofrequency in the treatment of large hepatocellular carcinoma", Eur J Gastroenterol Hepatol., vol. 25, issue 5, pp. 628-33, 2013. abstract.doc
EL Tayeb, M. A., N. El Sharnoubi, M. El Shenawi, and N. Abou El Ezz, "HYPERTONIC SALINE IN MANAGEMENT OF PEDIATRIC HEAD TRAUMA PATIENT. DOES IT MAKE A DIFFERENCE?", Scientific Journal Azhar University, vol. 29, issue 1, 2008.
Farahat, S. A., L. A. Rashed, A. M. Samir, and D. A. M. Hamid, "Hyperthyroidism among Galvanization Workers Due to Exposure to Zinc Fumes.", CEJOEM, vol. 13, issue (3-4), pp. 240-250, 2007.
SA, F., S. AM, A. - H. DM, and R. LA, "HYPERTHYROIDISM AMONG GALVANIZATION WORKERS DUE TO EXPOSURE TO ZINC FUMES ", Central European Journal of Occupational and Environmental Medicine, vol. 13, issue 3, pp. 240-249, 2007. hyperthyroidism_due_to_occupational_exposure_to_zinc_fumes.doc
Farahat, S. A., L. A. Rashed, A. M. Samir, and D. A. - H. Shaker, "HYPERTHYROIDISM AMONG GALVANIZATION WORKERS DUE TO EXPOSURE TO ZINC FUMES", Egyptian Journal of Occupational Medicine, vol. 13, issue 3, pp. 240–249, 2007. zinc_hyperthyroidism_ce7_3-04xx_1.pdf
Ahmed, M. M., M. T. Khayyal, and M. M. el-Merzabani, "Hyperthermic potentiation of cisplatin cytotoxicity on solid Ehrlich carcinoma.", Tumori, vol. 79, issue 4, pp. 268-72, 1993 Aug 31. Abstract

BACKGROUND: Hyperthermia produces marked effects on many biochemical parameters of tumor cells and has been reported to potentiate the effect of many drugs. We therefore evaluated the possible synergistic effect between hyperthermia and cisplatin against solid Ehrlich carcinoma. The study was based on the measurement of some biologic characteristics in tumor tissues, namely: DNA, RNA, and protein content and their rate of synthesis as parameters for nuclear damage; total lipids and cholesterol as parameters for membrane damage; acid-phosphatase and acid-ribonuclease as parameters for lysosomal damage; and tumor volume as a direct parameter for tumor growth.

METHODS: Treatment of solid Ehrlich carcinoma by hyperthermia at 43 degrees C for 30 min for 3 successive days produced a 41.5% decrease in tumor volume, as well as a significant decrease in nucleic acids, protein contents and their rate of synthesis, in total lipids and cholesterol, and in acid-phosphatase and acid-ribonuclease. Chemotherapeutic management of the tumor by 5 mg/kg x 3 of cisplatin alone showed a continuous increase in tumor volume but at a lower rate than that of the untreated control. However, when cisplatin was given 1 h prior to hyperthermia, the tumor volume was significantly decreased by 82.6%.

RESULTS: The effects observed on all the investigated parameter were intensified when cisplatin was combined with hyperthermia. The results obtained suggest that hyperthermia may enhance the penetration of cisplatin to its target site inside the tumor cells due to a membrane-damaging effect. The enhanced lethality of cisplatin on tumor cells may also be due to the inhibition of DNA repair processes by hyperthermia.

Ahmed, M. M., M. T. Khayyal, and M. M. el-Merzabani, "Hyperthermic potentiation of cisplatin cytotoxicity on solid Ehrlich carcinoma.", Tumori, vol. 79, issue 4, pp. 268-72, 1993 Aug 31. Abstract

BACKGROUND: Hyperthermia produces marked effects on many biochemical parameters of tumor cells and has been reported to potentiate the effect of many drugs. We therefore evaluated the possible synergistic effect between hyperthermia and cisplatin against solid Ehrlich carcinoma. The study was based on the measurement of some biologic characteristics in tumor tissues, namely: DNA, RNA, and protein content and their rate of synthesis as parameters for nuclear damage; total lipids and cholesterol as parameters for membrane damage; acid-phosphatase and acid-ribonuclease as parameters for lysosomal damage; and tumor volume as a direct parameter for tumor growth.

METHODS: Treatment of solid Ehrlich carcinoma by hyperthermia at 43 degrees C for 30 min for 3 successive days produced a 41.5% decrease in tumor volume, as well as a significant decrease in nucleic acids, protein contents and their rate of synthesis, in total lipids and cholesterol, and in acid-phosphatase and acid-ribonuclease. Chemotherapeutic management of the tumor by 5 mg/kg x 3 of cisplatin alone showed a continuous increase in tumor volume but at a lower rate than that of the untreated control. However, when cisplatin was given 1 h prior to hyperthermia, the tumor volume was significantly decreased by 82.6%.

RESULTS: The effects observed on all the investigated parameter were intensified when cisplatin was combined with hyperthermia. The results obtained suggest that hyperthermia may enhance the penetration of cisplatin to its target site inside the tumor cells due to a membrane-damaging effect. The enhanced lethality of cisplatin on tumor cells may also be due to the inhibition of DNA repair processes by hyperthermia.

Ahmed, M. M., M. T. Khayyal, and M. M. el-Merzabani, "Hyperthermic potentiation of cisplatin cytotoxicity on solid Ehrlich carcinoma.", Tumori, vol. 79, issue 4, pp. 268-72, 1993 Aug 31. Abstract

BACKGROUND: Hyperthermia produces marked effects on many biochemical parameters of tumor cells and has been reported to potentiate the effect of many drugs. We therefore evaluated the possible synergistic effect between hyperthermia and cisplatin against solid Ehrlich carcinoma. The study was based on the measurement of some biologic characteristics in tumor tissues, namely: DNA, RNA, and protein content and their rate of synthesis as parameters for nuclear damage; total lipids and cholesterol as parameters for membrane damage; acid-phosphatase and acid-ribonuclease as parameters for lysosomal damage; and tumor volume as a direct parameter for tumor growth.

METHODS: Treatment of solid Ehrlich carcinoma by hyperthermia at 43 degrees C for 30 min for 3 successive days produced a 41.5% decrease in tumor volume, as well as a significant decrease in nucleic acids, protein contents and their rate of synthesis, in total lipids and cholesterol, and in acid-phosphatase and acid-ribonuclease. Chemotherapeutic management of the tumor by 5 mg/kg x 3 of cisplatin alone showed a continuous increase in tumor volume but at a lower rate than that of the untreated control. However, when cisplatin was given 1 h prior to hyperthermia, the tumor volume was significantly decreased by 82.6%.

RESULTS: The effects observed on all the investigated parameter were intensified when cisplatin was combined with hyperthermia. The results obtained suggest that hyperthermia may enhance the penetration of cisplatin to its target site inside the tumor cells due to a membrane-damaging effect. The enhanced lethality of cisplatin on tumor cells may also be due to the inhibition of DNA repair processes by hyperthermia.

Amira, G., A. Morsi, I. S. Fayek, and O. Mansour, "hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in recurrent platinum-sensitive ovarian cancer: NCI case control study", Asian pacific journal of cancer prevention, vol. 20, issue 2, pp. 621-627, 2019. AbstractWebsite

Objectives: To assess the efficacy of cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal
chemotherapy (HIPEC) in recurrent platinum-sensitive ovarian cancer patients in comparison with standard intravenous
chemotherapy in terms of progression free survival and overall survival. Methods: Retrospective case control study
matching 15 cases with 20 controls with at least 24 months of follow up. Results: The two groups were comparable
and well matched in all aspects. Median follow up was 36 months in cases and 38 months in controls. The PFS2
revealed a median of 6 months (range 2-14) in cases and 5 months (range 2-18) in controls. The median OS was 36
and 38 months in cases and controls respectively. No statistically significant difference between the cases and controls
were observed in progression free survival (PFS2) and overall survival OS (P-value, 0.350 and 0.711 respectively).
However, the PFS2 was in favor of cases and OS was in favor of controls without reaching significance. The percentage
of patients who survived 5 years or more was 20% in cases and 35% in controls. The only issue in favor of HIPEC
is the significant reduction in chemotherapeutic toxicity when given by the intraperitoneal way (P- value 0.003).
Conclusion: According to our study, CRS and HIPEC do not seem to have impact on OS and PFS in the setting of
recurrent platinum sensitive ovarian cancer. However, we recommend on going researches with much more refined
selection criteria and with larger sample size.

Allam, R. S. H. M., and B. M. Ali, "Hypertensive uveitis: an initial presentation for primary antiphospholipid syndrome", Delta Journal of Ophthalmology, vol. 18, issue 3, pp. 185-189, 2017.
Allam, R. S. H. M., and B. M. Ali, "Hypertensive uveitis: an initial presentation for primary antiphospholipid syndrome", Delta J Ophthalmol, vol. 18, issue 3, pp. 185-189, 2017.
Allam, R. S. H. M., and B. M. Ali, "Hypertensive uveitis: an initial presentation for primary antiphospholipid syndrome", Delta Journal of Ophthalmology, vol. 18, issue 3, pp. 185-189, 2017.
Ibrahim, M. M., H. Rizk, L. Appel, W. ElAroussy, S. Helmy, Yasser Sharaf, Z. Ashour, H. Kandil, E. Roccella, and P. K. Whelton, "Hypertension Prevalence, Awareness, Treatment and Control in Egypt Results from the National Hypertension Project", Hypertension, vol. vol26, issue No 6,Part I, pp. 886=890, 1995.
Dayem, S. A. E. M., and A. H. M. E. D. A. BATTAH, "Hypertension in type 1 diabetic patients-the influence of body composition and body mass index: an observational study", Anatolian Journal of Cardiology, vol. 12, pp. 60-4, 2012.
Youssef, G., "Hypertension in pregnancy", E-Journal of Cardiology Practice, vol. 17, issue N° 22, 2019. escardio.org-hypertension_in_pregnancy.pdf
Arnaout, S. M., J. Ker, W. Almahmeed, M. Ibrahim, M. T. Khalil, C. V. T. Wyk, G. Mancia, and E. A. Mousa, "Hypertension and its management in countries in Africa and the Middle East, with special reference to the place of β-blockade.", Current Medical Research and Opinion , vol. 27, issue 6, pp. 1223-36, 2011. CU-PDF.pdf
Badr, E., and F. Bars, "Hypersurface model-fields of definition for smooth hypersurfaces and their twists", Acta Arithmetica, vol. 194, pp. 267-280, 2020.
Fayed, H. A., A. F. Atiya, and S. R. Hashem, "Hyperspherical Prototypes for Pattern Classification", International Journal of Pattern Recognition and Artificial Intelligence, vol. 23, issue 8, pp. 1549-1575, 2009.
Fayed, H. A., A. F. Atiya, and S. H. E. R. I. F. M. R. HASHEM, "Hyperspherical Prototypes for Pattern Classification", International Journal of Pattern Recognition and Artificial Intelligence, vol. 23, pp. 1549–1575, 2009. Abstract
n/a
Rashed, Y. F., M. H. Aliabadi, and C. A. Brebbia, "Hypersingular boundary element formulation for Reissner plates", International journal of solids and structures, vol. 35, no. 18: Pergamon, pp. 2229–2249, 1998. Abstract
n/a
Rashed, Y. F., M. H. Aliabadi, and C. A. Brebbia, "Hypersingular boundary element formulation for Reissner plates", International journal of solids and structures, vol. 35, no. 18: Pergamon, pp. 2229–2249, 1998. Abstract
n/a
Rashed, Y. F., M. H. Aliabadi, and C. A. Brebbia, "Hypersingular boundary element formulation for Reissner plates", International journal of solids and structures, vol. 35, no. 18: Pergamon, pp. 2229–2249, 1998. Abstract
n/a
Rashed, Y. F., M. H. Aliabadi, and C. A. Brebbia, "Hypersingular boundary element formulation for Reissner plates", International journal of solids and structures, vol. 35, no. 18: Pergamon, pp. 2229–2249, 1998. Abstract
n/a
Tourism